DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market 2014 - 2020" report to their offering.
The report covers forecast and analysis for the depression drug market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million). The study includes drivers and restraints for the depression drug market along with the impact they have on the demand over the forecast period.
In order to give the users of this report a comprehensive view on the depression drug market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's five forces model for the depression drug market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.
The study provides a decisive view on the depression drug market by segmenting the market based class and region. The different classes of depression also have different symptoms, including major or clinical depressive disorder, postpartum depression, dysthymic disorder, psychotic depression and seasonal affective disorder. Depending upon class global depression drug market is segmented as anticonvulsants, serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors (SSRIs), beta-blockers, benzodiazepines, tetracyclic antidepressants (TeCAs) and monoamine oxidase inhibitors (MAOIs) among others.
Companies Mentioned:
- Forest Laboratories
- AstraZeneca
- Eli Lilly and Company
- H. Lundbeck, Merck & Co.
- GlaxoSmithKline
- Naurex
- Novartis
- SK Biopharmaceuticals
Report Structure:
1. Introduction
2. Executive Summary
3. Depression drug market - Global and Industry Analysis
4. Global Depression drug market - Competitive Landscape
5. Global Depression drug market : Class Overview
6. Global Depression drug market - Regional Segment Analysis
7. Company Profile
For more information visit http://www.researchandmarkets.com/research/3x39jw/depression_drug
